Atlas Trials

A Phase II Trial of Stereotactic Body Radiotherapy With Concurrent Anti-PD1 Treatment in Metastatic Melanoma.

Clinical trial NCT02821182 · COMPLETED

Trial details

NCT number
NCT02821182
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2016-09-01
Primary completion
2018-09-09
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.